Testing the Integrated mHealth App Intervention SiS-H - Trial NCT05886621
Access comprehensive clinical trial information for NCT05886621 through Pure Global AI's free database. This phase not specified trial is sponsored by Massachusetts General Hospital and is currently Not yet recruiting. The study focuses on Smoking Cessation. Target enrollment is 64 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Massachusetts General Hospital
Timeline & Enrollment
N/A
Aug 01, 2023
Oct 01, 2024
Primary Outcome
App usage
Summary
The present study is a pilot randomized controlled trial (RCT) that seeks to test the
 feasibility, acceptability, process outcomes, and exploratory outcomes of a newly integrated,
 app-based smoking cessation treatment (SiS-H, which stands for Smiling instead of Smoking
 for people with HIV) for people with HIV who smoke. This treatment will be compared to
 onboarding to the National Cancer Institute's smartphone app QuitGuide (QG). Persons with
 HIV who smoke and are engaged in HIV clinical care (n=64) will be randomized (1:1) to smoking
 cessation support via SiS-H vs. QuitGuide.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT05886621
Non-Device Trial